Type |
Details |
Score |
GXD Expression |
Probe: |
MGI:2663745 |
Assay Type: |
RNA in situ |
Annotation Date: |
2003-07-21 |
Strength: |
Strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689417 |
Pattern: |
Not Specified |
Stage: |
TS17 |
Assay Id: |
MGI:2666304 |
Age: |
embryonic day 10.5 |
Image: |
Dyrk1a 10.5dpc |
|
Specimen Label: |
Dyrk1a 10.5dpc |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2663746 |
Assay Type: |
RNA in situ |
Annotation Date: |
2003-07-21 |
Strength: |
Strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689417 |
Pattern: |
Not Specified |
Stage: |
TS17 |
Assay Id: |
MGI:2666305 |
Age: |
embryonic day 10.5 |
Image: |
Dyrk1a 10.5dpc |
|
Specimen Label: |
Dyrk1a 10.5dpc |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2663745 |
Assay Type: |
RNA in situ |
Annotation Date: |
2003-07-21 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:1796222 |
Pattern: |
Uniform |
Stage: |
TS22 |
Assay Id: |
MGI:2666304 |
Age: |
embryonic day 14.5 |
Image: |
Dyrk1a 14.5dpc |
|
Specimen Label: |
Dyrk1a 14.5dpc |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2663746 |
Assay Type: |
RNA in situ |
Annotation Date: |
2003-07-21 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:1796222 |
Pattern: |
Uniform |
Stage: |
TS22 |
Assay Id: |
MGI:2666305 |
Age: |
embryonic day 14.5 |
Image: |
Dyrk1a 14.5dpc |
|
Specimen Label: |
Dyrk1a 14.5dpc |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
Publication |
First Author: |
Renon M |
Year: |
2016 |
Journal: |
Biochim Biophys Acta |
Title: |
Impact of Dyrk1A level on alcohol metabolism. |
Volume: |
1862 |
Issue: |
9 |
Pages: |
1495-503 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
87
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Jung MS |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. |
Volume: |
286 |
Issue: |
46 |
Pages: |
40401-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee Y |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis. |
Volume: |
284 |
Issue: |
48 |
Pages: |
33343-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dirice E |
Year: |
2016 |
Journal: |
Diabetes |
Title: |
Inhibition of DYRK1A Stimulates Human β-Cell Proliferation. |
Volume: |
65 |
Issue: |
6 |
Pages: |
1660-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park J |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. |
Volume: |
285 |
Issue: |
41 |
Pages: |
31895-906 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rachdi L |
Year: |
2014 |
Journal: |
Cell Cycle |
Title: |
Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance. |
Volume: |
13 |
Issue: |
14 |
Pages: |
2221-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Souchet B |
Year: |
2014 |
Journal: |
Neurobiol Dis |
Title: |
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage. |
Volume: |
69 |
|
Pages: |
65-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dard R |
Year: |
2021 |
Journal: |
Genes (Basel) |
Title: |
DYRK1A Overexpression in Mice Downregulates the Gonadotropic Axis and Disturbs Early Stages of Spermatogenesis. |
Volume: |
12 |
Issue: |
11 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ahn KJ |
Year: |
2006 |
Journal: |
Neurobiol Dis |
Title: |
DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. |
Volume: |
22 |
Issue: |
3 |
Pages: |
463-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo X |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. |
Volume: |
285 |
Issue: |
17 |
Pages: |
13223-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kariyawasam D |
Year: |
2015 |
Journal: |
Endocrinology |
Title: |
DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome. |
Volume: |
156 |
Issue: |
3 |
Pages: |
1171-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rozen EJ |
Year: |
2018 |
Journal: |
Cell Rep |
Title: |
DYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells. |
Volume: |
23 |
Issue: |
6 |
Pages: |
1867-1878 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park JH |
Year: |
2012 |
Journal: |
J Neurochem |
Title: |
Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α. |
Volume: |
122 |
Issue: |
5 |
Pages: |
1081-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kurabayashi N |
Year: |
2010 |
Journal: |
Mol Cell Biol |
Title: |
DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping. |
Volume: |
30 |
Issue: |
7 |
Pages: |
1757-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tlili A |
Year: |
2013 |
Journal: |
Mol Genet Metab |
Title: |
DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels. |
Volume: |
110 |
Issue: |
3 |
Pages: |
371-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hille S |
Year: |
2016 |
Journal: |
Cardiovasc Res |
Title: |
Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling. |
Volume: |
110 |
Issue: |
3 |
Pages: |
381-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Toiber D |
Year: |
2010 |
Journal: |
Neurobiol Dis |
Title: |
Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations. |
Volume: |
40 |
Issue: |
1 |
Pages: |
348-59 |
|
•
•
•
•
•
|
Publication |
First Author: |
Laguna A |
Year: |
2008 |
Journal: |
Dev Cell |
Title: |
The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. |
Volume: |
15 |
Issue: |
6 |
Pages: |
841-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Noll C |
Year: |
2012 |
Journal: |
Mol Genet Metab |
Title: |
Dyrk1a activates antioxidant NQO1 expression through an ERK1/2-Nrf2 dependent mechanism. |
Volume: |
105 |
Issue: |
3 |
Pages: |
484-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Laguna A |
Year: |
2013 |
Journal: |
Hum Mol Genet |
Title: |
Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome. |
Volume: |
22 |
Issue: |
14 |
Pages: |
2775-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shih YT |
Year: |
2023 |
Journal: |
Neuron |
Title: |
An inhibitory circuit-based enhancer of DYRK1A function reverses Dyrk1a-associated impairment in social recognition. |
Volume: |
111 |
Issue: |
19 |
Pages: |
3084-3101.e5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Khor B |
Year: |
2015 |
Journal: |
Elife |
Title: |
The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells. |
Volume: |
4 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Tateossian H |
Year: |
2025 |
Journal: |
Elife |
Title: |
DYRK1A kinase triplication is the major cause of Otitis Media in Down Syndrome. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Arron JR |
Year: |
2006 |
Journal: |
Nature |
Title: |
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. |
Volume: |
441 |
Issue: |
7093 |
Pages: |
595-600 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2021 |
Journal: |
Blood |
Title: |
DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis. |
Volume: |
138 |
Issue: |
23 |
Pages: |
2360-2371 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kurabayashi N |
Year: |
2015 |
Journal: |
EMBO Rep |
Title: |
DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model. |
Volume: |
16 |
Issue: |
11 |
Pages: |
1548-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martínez de Lagrán M |
Year: |
2004 |
Journal: |
Neurobiol Dis |
Title: |
Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction. |
Volume: |
15 |
Issue: |
1 |
Pages: |
132-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hawley LE |
Year: |
2023 |
Journal: |
Neurobiol Dis |
Title: |
Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model. |
Volume: |
190 |
|
Pages: |
106359 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martinez de Lagran M |
Year: |
2012 |
Journal: |
Cereb Cortex |
Title: |
Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons. |
Volume: |
22 |
Issue: |
12 |
Pages: |
2867-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sitz JH |
Year: |
2004 |
Journal: |
Mol Cell Biol |
Title: |
Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4. |
Volume: |
24 |
Issue: |
13 |
Pages: |
5821-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rachdi L |
Year: |
2014 |
Journal: |
Diabetologia |
Title: |
Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass. |
Volume: |
57 |
Issue: |
5 |
Pages: |
960-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thompson BJ |
Year: |
2015 |
Journal: |
J Exp Med |
Title: |
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3. |
Volume: |
212 |
Issue: |
6 |
Pages: |
953-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fotaki V |
Year: |
2002 |
Journal: |
Mol Cell Biol |
Title: |
Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. |
Volume: |
22 |
Issue: |
18 |
Pages: |
6636-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arranz J |
Year: |
2019 |
Journal: |
Neurobiol Dis |
Title: |
Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome. |
Volume: |
127 |
|
Pages: |
210-222 |
|
•
•
•
•
•
|
Publication |
First Author: |
Strine MS |
Year: |
2023 |
Journal: |
PLoS Biol |
Title: |
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner. |
Volume: |
21 |
Issue: |
6 |
Pages: |
e3002097 |
|
•
•
•
•
•
|
Publication |
First Author: |
Elagib KE |
Year: |
2022 |
Journal: |
J Clin Invest |
Title: |
Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes. |
Volume: |
132 |
Issue: |
19 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ortiz-Abalia J |
Year: |
2008 |
Journal: |
Am J Hum Genet |
Title: |
Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome. |
Volume: |
83 |
Issue: |
4 |
Pages: |
479-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barallobre MJ |
Year: |
2014 |
Journal: |
Cell Death Dis |
Title: |
DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease. |
Volume: |
5 |
|
Pages: |
e1289 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fotaki V |
Year: |
2004 |
Journal: |
Behav Neurosci |
Title: |
Haploinsufficiency of Dyrk1A in mice leads to specific alterations in the development and regulation of motor activity. |
Volume: |
118 |
Issue: |
4 |
Pages: |
815-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martí E |
Year: |
2003 |
Journal: |
Brain Res |
Title: |
Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. |
Volume: |
964 |
Issue: |
2 |
Pages: |
250-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lepagnol-Bestel AM |
Year: |
2009 |
Journal: |
Hum Mol Genet |
Title: |
DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. |
Volume: |
18 |
Issue: |
8 |
Pages: |
1405-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xiang J |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome. |
Volume: |
114 |
Issue: |
7 |
Pages: |
E1224-E1233 |
|
•
•
•
•
•
|
Publication |
First Author: |
Neumann F |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives. |
Volume: |
8 |
Issue: |
1 |
Pages: |
2859 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tlili A |
Year: |
2013 |
Journal: |
Biochim Biophys Acta |
Title: |
Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice. |
Volume: |
1832 |
Issue: |
6 |
Pages: |
718-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
McElyea SD |
Year: |
2016 |
Journal: |
Hum Mol Genet |
Title: |
Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. |
Volume: |
25 |
Issue: |
22 |
Pages: |
4856-4869 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lana-Elola E |
Year: |
2024 |
Journal: |
Sci Transl Med |
Title: |
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome. |
Volume: |
16 |
Issue: |
731 |
Pages: |
eadd6883 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kurabayashi N |
Year: |
2013 |
Journal: |
Genes Dev |
Title: |
Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells. |
Volume: |
27 |
Issue: |
24 |
Pages: |
2708-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Levy JA |
Year: |
2021 |
Journal: |
Biol Psychiatry |
Title: |
Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling. |
Volume: |
90 |
Issue: |
5 |
Pages: |
295-306 |
|
•
•
•
•
•
|
Publication |
First Author: |
Altafaj X |
Year: |
2001 |
Journal: |
Hum Mol Genet |
Title: |
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. |
Volume: |
10 |
Issue: |
18 |
Pages: |
1915-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arque G |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Dyrk1A is dynamically expressed on subsets of motor neurons and in the neuromuscular junction: possible role in Down syndrome. |
Volume: |
8 |
Issue: |
1 |
Pages: |
e54285 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grebe C |
Year: |
2011 |
Journal: |
Cardiovasc Res |
Title: |
Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo. |
Volume: |
90 |
Issue: |
3 |
Pages: |
521-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
García-Cerro S |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome. |
Volume: |
9 |
Issue: |
9 |
Pages: |
e106572 |
|
•
•
•
•
•
|
Publication |
First Author: |
Altafaj X |
Year: |
2013 |
Journal: |
Neurobiol Dis |
Title: |
Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. |
Volume: |
52 |
|
Pages: |
117-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Classen J |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
A Munc18-1 mutant mimicking phosphorylation by Down Syndrome-related kinase Dyrk1a supports normal synaptic transmission and promotes recovery after intense activity. |
Volume: |
10 |
Issue: |
1 |
Pages: |
3181 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ferron SR |
Year: |
2010 |
Journal: |
Cell Stem Cell |
Title: |
Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling. |
Volume: |
7 |
Issue: |
3 |
Pages: |
367-79 |
|
•
•
•
•
•
|
Publication |
First Author: |
García-Cerro S |
Year: |
2017 |
Journal: |
Neurobiol Dis |
Title: |
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes. |
Volume: |
106 |
|
Pages: |
76-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li D |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactions. |
Volume: |
285 |
Issue: |
46 |
Pages: |
35374-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Redhead Y |
Year: |
2023 |
Journal: |
Development |
Title: |
Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes. |
Volume: |
150 |
Issue: |
8 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Branchi I |
Year: |
2004 |
Journal: |
J Neuropathol Exp Neurol |
Title: |
Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. |
Volume: |
63 |
Issue: |
5 |
Pages: |
429-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Malinge S |
Year: |
2012 |
Journal: |
J Clin Invest |
Title: |
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. |
Volume: |
122 |
Issue: |
3 |
Pages: |
948-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brault V |
Year: |
2021 |
Journal: |
PLoS Genet |
Title: |
Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome. |
Volume: |
17 |
Issue: |
9 |
Pages: |
e1009777 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thomazeau A |
Year: |
2014 |
Journal: |
J Neurosci |
Title: |
Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. |
Volume: |
34 |
Issue: |
4 |
Pages: |
1138-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ryoo SR |
Year: |
2007 |
Journal: |
J Biol Chem |
Title: |
DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. |
Volume: |
282 |
Issue: |
48 |
Pages: |
34850-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Viard J |
Year: |
2022 |
Journal: |
Life Sci Alliance |
Title: |
Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease. |
Volume: |
5 |
Issue: |
12 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Tejedor F |
Year: |
1995 |
Journal: |
Neuron |
Title: |
minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. |
Volume: |
14 |
Issue: |
2 |
Pages: |
287-301 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marechal D |
Year: |
2019 |
Journal: |
Hum Mol Genet |
Title: |
Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a. |
Volume: |
28 |
Issue: |
9 |
Pages: |
1561-1577 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jiang X |
Year: |
2015 |
Journal: |
Hum Mol Genet |
Title: |
Genetic dissection of the Down syndrome critical region. |
Volume: |
24 |
Issue: |
22 |
Pages: |
6540-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guedj F |
Year: |
2012 |
Journal: |
Neurobiol Dis |
Title: |
DYRK1A: a master regulatory protein controlling brain growth. |
Volume: |
46 |
Issue: |
1 |
Pages: |
190-203 |
|
•
•
•
•
•
|
Publication |
First Author: |
Benavides-Piccione R |
Year: |
2005 |
Journal: |
Neurobiol Dis |
Title: |
Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse. |
Volume: |
20 |
Issue: |
1 |
Pages: |
115-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Granno S |
Year: |
2019 |
Journal: |
Sci Rep |
Title: |
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus. |
Volume: |
9 |
Issue: |
1 |
Pages: |
7322 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cortes DE |
Year: |
2024 |
Journal: |
Sci Adv |
Title: |
An in vitro neurogenetics platform for precision disease modeling in the mouse. |
Volume: |
10 |
Issue: |
14 |
Pages: |
eadj9305 |
|
•
•
•
•
•
|
Publication |
First Author: |
Raveau M |
Year: |
2018 |
Journal: |
Neurobiol Dis |
Title: |
DYRK1A-haploinsufficiency in mice causes autistic-like features and febrile seizures. |
Volume: |
110 |
|
Pages: |
180-191 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu K |
Year: |
2024 |
Journal: |
Commun Biol |
Title: |
MicroRNA-221-3p inhibits the inflammatory response of keratinocytes by regulating the DYRK1A/STAT3 signaling pathway to promote wound healing in diabetes. |
Volume: |
7 |
Issue: |
1 |
Pages: |
300 |
|
•
•
•
•
•
|
Publication |
First Author: |
Altafaj X |
Year: |
2008 |
Journal: |
Neurobiol Dis |
Title: |
Increased NR2A expression and prolonged decay of NMDA-induced calcium transient in cerebellum of TgDyrk1A mice, a mouse model of Down syndrome. |
Volume: |
32 |
Issue: |
3 |
Pages: |
377-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Watson-Scales S |
Year: |
2018 |
Journal: |
PLoS Genet |
Title: |
Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration. |
Volume: |
14 |
Issue: |
5 |
Pages: |
e1007383 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martinez de Lagran M |
Year: |
2007 |
Journal: |
Genes Brain Behav |
Title: |
Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-). |
Volume: |
6 |
Issue: |
6 |
Pages: |
569-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blazek JD |
Year: |
2015 |
Journal: |
Hum Mol Genet |
Title: |
Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a. |
Volume: |
24 |
Issue: |
20 |
Pages: |
5687-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manubens-Gil L |
Year: |
2024 |
Journal: |
Cereb Cortex |
Title: |
Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A. |
Volume: |
34 |
Issue: |
1 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Kida E |
Year: |
2011 |
Journal: |
Neuroscience |
Title: |
Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals. |
Volume: |
195 |
|
Pages: |
112-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fernandez-Martinez J |
Year: |
2009 |
Journal: |
J Cell Sci |
Title: |
Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. |
Volume: |
122 |
Issue: |
Pt 10 |
Pages: |
1574-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sitz JH |
Year: |
2008 |
Journal: |
Neuroscience |
Title: |
The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4. |
Volume: |
157 |
Issue: |
3 |
Pages: |
596-605 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qian W |
Year: |
2011 |
Journal: |
Nucleic Acids Res |
Title: |
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. |
Volume: |
39 |
Issue: |
14 |
Pages: |
6161-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Noll C |
Year: |
2009 |
Journal: |
PLoS One |
Title: |
DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase. |
Volume: |
4 |
Issue: |
10 |
Pages: |
e7540 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kaczmarski W |
Year: |
2014 |
Journal: |
J Neurosci Res |
Title: |
Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). |
Volume: |
92 |
Issue: |
2 |
Pages: |
162-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Aranda S |
Year: |
2008 |
Journal: |
Mol Cell Biol |
Title: |
Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. |
Volume: |
28 |
Issue: |
19 |
Pages: |
5899-911 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang P |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A Gene Transcription is regulated by Myocyte Enhancer Factor 2D. |
Volume: |
7 |
Issue: |
1 |
Pages: |
7240 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arqué G |
Year: |
2008 |
Journal: |
PLoS One |
Title: |
Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A). |
Volume: |
3 |
Issue: |
7 |
Pages: |
e2575 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ruiz-Mejias M |
Year: |
2016 |
Journal: |
J Neurosci |
Title: |
Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex. |
Volume: |
36 |
Issue: |
13 |
Pages: |
3648-59 |
|
•
•
•
•
•
|
Publication |
First Author: |
Velazquez R |
Year: |
2019 |
Journal: |
Mol Neurobiol |
Title: |
Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice. |
Volume: |
56 |
Issue: |
12 |
Pages: |
8364-8375 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tian S |
Year: |
2019 |
Journal: |
J Biol Chem |
Title: |
Dual-specificity tyrosine phosphorylation-regulated kinase 1A ameliorates insulin resistance in neurons by up-regulating IRS-1 expression. |
Volume: |
294 |
Issue: |
52 |
Pages: |
20164-20176 |
|
•
•
•
•
•
|
Publication |
First Author: |
Canzonetta C |
Year: |
2008 |
Journal: |
Am J Hum Genet |
Title: |
DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. |
Volume: |
83 |
Issue: |
3 |
Pages: |
388-400 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lan C |
Year: |
2022 |
Journal: |
EBioMedicine |
Title: |
Inhibition of DYRK1A, via histone modification, promotes cardiomyocyte cell cycle activation and cardiac repair after myocardial infarction. |
Volume: |
82 |
|
Pages: |
104139 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lana-Elola E |
Year: |
2023 |
Journal: |
bioRxiv |
Title: |
Congenital heart defects in Down syndrome are caused by increased dosage of DYRK1A. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Becker W |
Year: |
1998 |
Journal: |
J Biol Chem |
Title: |
Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. |
Volume: |
273 |
Issue: |
40 |
Pages: |
25893-902 |
|
•
•
•
•
•
|
Publication |
First Author: |
Branca C |
Year: |
2017 |
Journal: |
Aging Cell |
Title: |
Dyrk1 inhibition improves Alzheimer's disease-like pathology. |
Volume: |
16 |
Issue: |
5 |
Pages: |
1146-1154 |
|
•
•
•
•
•
|